tiprankstipranks
Trending News
More News >

BeOne Medicines Ltd. Forms Scientific Advisory Committee to Boost R&D Oversight

Story Highlights
BeOne Medicines Ltd. Forms Scientific Advisory Committee to Boost R&D Oversight

Confident Investing Starts Here:

An update from BeiGene Ltd ( (HK:6160) ) is now available.

BeOne Medicines Ltd. has established a Scientific Advisory Committee to enhance its board’s oversight of research and development activities, providing strategic scientific guidance. This move aims to bolster the company’s R&D capabilities, ensuring alignment with its strategic goals, and potentially strengthening its position within the pharmaceutical industry.

The most recent analyst rating on (HK:6160) stock is a Buy with a HK$148.40 price target. To see the full list of analyst forecasts on BeiGene Ltd stock, see the HK:6160 Stock Forecast page.

More about BeiGene Ltd

Average Trading Volume: 6,619,453

Technical Sentiment Signal: Strong Buy

Current Market Cap: HK$235.8B

Learn more about 6160 stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App